| | More

Lung Cancer Week

Lung Cancer Week

Lung Cancer Week

Welcome Message

At some point in their lifetime, 1 in 14 people in the United States will hear the words, “you have lung cancer.” These patients—more than 228,000 of whom will be diagnosed this year—seek information, support, and effective treatment. Their loved ones are also deeply impacted: emotionally, physically, and financially. Lung cancer can come in a variety of forms and be aggressive or relatively benign. Although smoking is a major risk factor for lung cancer, it can affect anyone, whether or not they have a history of smoking.

Lung cancer is one of the world’s most challenging malignancies due to its high prevalence, late-stage average diagnosis, complex tissue types and biology, and limited treatment options. But things are changing. New screening techniques, innovative treatments, improved understanding of lung cancer genetics and early integration of palliative care are making the disease more manageable than ever. Furthermore, lung cancer incidence is decreasing in more industrialized countries, largely as a result of successful smoking prevention and cessation programs.

Now is not the time to stand down, however. Now is the time to build on our progress in symptom recognition, patient support and an increased commitment to fund lifesaving research.

“Lung Disease Week at the ATS” provides a forum for discussing important lung cancer issues. The American Thoracic Society (ATS) and the National Lung Cancer Partnership support new and more efficacious interventions in prevention, screening, treatment, care and survivorship for individuals at risk for and affected by lung cancer. This “Lung Cancer Week” seeks to improve awareness of lung cancer and its impact on people every day, helping to lay the groundwork for increasing research funding and improving patient’s options. We look forward to the opportunities that our continued collaboration can bring to the movement to defeat lung cancer.

Lynn F. Reinke, PhD, APRN, BC

Lynn F. Reinke, PhD, APRN, BC
Research Investigator
Dept of Veterans Affairs
Chair, ATS Nursing Assembly
Member, ATS Board of Directors

Regina Vidaver, PhD

Regina Vidaver, PhD
Executive Director
National Lung Cancer Partnership
Chair, ATS Public Advisory Roundtable

ATS Lung Cancer Partner – National Lung Cancer Partnership

National Lung Cancer Partnership

The National Lung Cancer Partnership is the only lung cancer advocacy organization founded by doctors and researchers working together with survivors and advocates to increase lung cancer awareness and research funding.

Headquartered in Madison, WI, the Partnership supports a nationwide network of grassroots lung cancer advocates through its programs. The Partnership has official state chapters in Florida, Louisiana and Pennsylvania.

Their mission is to decrease deaths due to lung cancer and to help patients live longer and better through research, awareness and advocacy.

 

Disclaimer: "The ATS Lung Disease Week Web site is designed for educational purposes only. You should not rely on this information as a substitute for personal medical attention, a diagnosis from a physician, or direct medical care. If you are concerned about your health or that of a family member, please consult your family's healthcare provider immediately. Do not wait for a response from our members, staff or partners."